title: The probable role of tumor stem cells for lymph node metastasis in supraglottic carcinoma.
abstract: Tumor stem cells (TSC), which are considered as likely candidates for the origin of cancer, are deduced to be responsible for tumor metastasis theoretically. We therefore investigated whether TSC were associated with lymph node metastasis in supraglottic carcinoma. Immunohistochemistry was performed for CD44, CD133, and LYVE-1 to detect TSC and lymphatic vessel density (LVD) in 66 primary supraglottic carcinoma tissue samples from 30 patients with lymph node metastasis (N+) and 36 patients without (N0). Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot were used to detect the expression of CD44 and CD133 at mRNA and protein levels in N+ and N0 primary tumors. The LVD was 22.4 ± 10.26 in 30N+ and 6.8 ± 4.09 in 36N0 samples subjected to immunohistochemistry, which was associated with their clinical nodal stages. There were 43.33% CD44-positive and 93.33% CD133-positive samples in 30N +, and 13.89% CD44-positive and 44.44% CD133-positive samples in 36N0 (P < 0.05). However, in each positive slide, there were only 5∼10% CD44-positive cells, but 70∼85% CD133-possitive cells. The expressions of CD44 and CD133 of N+ obtained through RT-PCR and Western blot were significantly higher than those of N0. These results suggest that TSC identified through CD44-positive cells in N+ were significantly higher than those in N0, indicating that TSC may be responsible for lymph node metastasis. CD133, whose expression is not restricted to TSC, may be unspecific for TSC identification in hypostatic supraglottic carcinoma.
authors.affiliation: Institute of Eye and ENT, Provincial Hospital affiliated to Shandong University, Jinan, 250021, People's Republic of China.
authors.forename: Sumei
authors.initials: S
authors.lastname: Lu
authors.forename: Jiajun
authors.initials: J
authors.lastname: Tian
authors.forename: Zhenghua
authors.initials: Z
authors.lastname: Lv
authors.forename: Haibo
authors.initials: H
authors.lastname: Wang
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Bai
authors.forename: Wenwen
authors.initials: W
authors.lastname: Liu
authors.forename: Jianfeng
authors.initials: J
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
mesh_terms: D000071916:AC133 Antigen; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000032:analysis / Q000096:biosynthesis; D014408:Biomarkers, Tumor / Q000032:analysis; D015153:Blotting, Western; D002277:Carcinoma / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006023:Glycoproteins / Q000032:analysis / Q000096:biosynthesis; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis / Q000096:biosynthesis; D007150:Immunohistochemistry; D007822:Laryngeal Neoplasms / Q000378:metabolism / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology*; D010455:Peptides / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D018960:Hyaluronan Receptors; C000606023:PROM1 protein, human; D010455:Peptides
references.citation: J Oral Pathol Med. 2007 Nov;36(10):594-603
references.pmid: 17944752
references.citation: Cancer Lett. 2008 May 18;263(2):223-30
references.pmid: 18289774
references.citation: Annu Rev Med. 2007;58:267-84
references.pmid: 17002552
references.citation: Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1065-70
references.pmid: 16365219
references.citation: Hum Pathol. 2006 Jun;37(6):719-25
references.pmid: 16733213
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):6751-60
references.pmid: 18980968
references.citation: World J Gastroenterol. 2009 May 14;15(18):2258-64
references.pmid: 19437567
references.citation: J Pathol. 2005 Jun;206(2):170-7
references.pmid: 15846845
references.citation: J Clin Invest. 2008 Jun;118(6):2111-20
references.pmid: 18497886
references.citation: In Vivo. 2008 Jan-Feb;22(1):89-92
references.pmid: 18396788
references.citation: PLoS One. 2008;3(11):e3655
references.pmid: 18985161
references.citation: Eur Arch Otorhinolaryngol. 2008 Jan;265(1):17-20
references.pmid: 17934745
references.citation: Mod Pathol. 2007 Jun;20(6):694-700
references.pmid: 17464319
references.citation: Cancer Res. 2003 Apr 15;63(8):1920-6
references.pmid: 12702584
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2871-5
references.pmid: 18539966
references.citation: J Cell Sci. 2004 Jul 15;117(Pt 16):3539-45
references.pmid: 15226377
references.citation: PLoS One. 2008;3(10):e3544
references.pmid: 18958156
references.citation: Head Neck. 2009 Jan;31(1):94-101
references.pmid: 18853445
references.citation: Cell. 2006 Mar 24;124(6):1111-5
references.pmid: 16564000
references.citation: BMC Cancer. 2008 Feb 08;8:48
references.pmid: 18261235
references.citation: Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6
references.pmid: 16488983
references.citation: Cancer Res. 2007 Apr 15;67(8):3716-24
references.pmid: 17440084
references.citation: Radiother Oncol. 2005 Nov;77(2):172-5
references.pmid: 16229916
references.citation: Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):92-7
references.pmid: 17287174
references.citation: J Oral Pathol Med. 2008 Nov;37(10):616-25
references.pmid: 19012622
references.citation: Breast Cancer Res. 2008;10(1):R10
references.pmid: 18241344
references.citation: Nat Rev Cancer. 2003 Dec;3(12):895-902
references.pmid: 14737120
references.citation: Methods Mol Biol. 2009;568:175-93
references.pmid: 19582427